Bilanx Investment
Overview
Bilanx Investment is a South Korean venture capital firm that invests in a variety of sectors, with a focus on Series A rounds.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Neocannbio | Sep 2023 | Series B | Lead |
| Dosigotgan | Sep 2024 | Series A Extension | Co-investor |
| GINT Co.,Ltd. | Dec 2025 | Private Equity | Co-investor |
| Egnis Inc. | Sep 2023 | Series B | Co-investor |
| ELROILAB | Jan 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Bilanx Investment based?
Bilanx Investment is headquartered in Seoul, South Korea.
When was Bilanx Investment founded?
Bilanx Investment was founded in 2021.
How many portfolio companies does Bilanx Investment have?
Bilanx Investment has 5 portfolio companies in Caplight's dataset.
What are some companies in Bilanx Investment's portfolio?
Portfolio companies visible on Caplight include Neocannbio, Dosigotgan, GINT Co.,Ltd., Egnis Inc., ELROILAB.
What was Bilanx Investment's most recent investment shown here?
Bilanx Investment's most recent investment in this portfolio sample was in GINT Co.,Ltd. in 2025.
What sectors does Bilanx Investment focus on?
Bilanx Investment focuses on Consumer & Commerce, Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences.
What company stages does Bilanx Investment focus on?
Bilanx Investment typically invests at the Early stage.